Combination Stem Cell (MESENDO) Therapy for Utilization and Rescue of Infarcted Myocardium

NCT00548613 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease
Coronary Arteriosclerosis
Coronary Atherosclerosis
Coronary Disease

Interventions

BIOLOGICAL: MESENDO
BIOLOGICAL: MESENDO

Sponsor

TCA Cellular Therapy